Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...
Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...
Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...
Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...
Pancreatic cancer is notoriously difficult to detect early, as it often does not present any noticeable symptoms until it has ...